Patents by Inventor Ebo D. de Muinck

Ebo D. de Muinck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dendritic cell modulation in post-ischemic wounds
    Patent number: 9233137
    Abstract: Compositions and methods useful for targeted depletion or modulation of dendritic cells are provided. The compositions and methods can be used to promote healing of ischemia-related injury, including ischemia-reperfusion injury. Disclosed are a variety of dendritic cell-targeted toxins, bone morphogenetic protein 7 (BMP7) agonists, and dendritic cell-targeted transforming growth factor beta 1 (TGF-?1) antagonists, all useful in practicing methods of the invention. The inventive compositions and methods can be used in the treatment of various conditions including myocardial infarction, stroke, and critical limb ischemia.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: January 12, 2016
    Assignee: Celdara Medical, LLC
    Inventors: Ebo D. de Muinck, Jose R. Conejo-Garcia
  • DENDRITIC CELL MODULATION IN POST-ISCHEMIC WOUNDS
    Publication number: 20120039985
    Abstract: Compositions and methods useful for targeted depletion or modulation of dendritic cells are provided. The compositions and methods can be used to promote healing of ischemia-related injury, including ischemia-reperfusion injury. Disclosed are a variety of dendritic cell-targeted toxins, bone morphogenetic protein 7 (BMP7) agonists, and dendritic cell-targeted transforming growth factor beta 1 (TGF-?1) antagonists, all useful in practicing methods of the invention. The inventive compositions and methods can be used in the treatment of various conditions including myocardial infarction, stroke, and critical limb ischemia.
    Type: Application
    Filed: November 6, 2009
    Publication date: February 16, 2012
    Inventors: Ebo D. de Muinck, Jose R. Conejo-Garcia